The results that rhIL‐12 can increase the anti‐tumor activity of CEA‐CAR‐T cells provide us a referential strategy to use other cytokines to strengthen the anti‐tumor activity of CAR‐T cells. Here, CEACAM5 is linked to neoplasm.